Adults with Prader–Willi Syndrome have Weaker Bones: Effect of Treatment with GH and Sex Steroids

Silvia Longhi, Graziano Grugni, Davide Gatti, Emiliano Spinozzi, Alessandro Sartorio, Silvano Adami, Antonio Fanolla, Giorgio Radetti

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Obesity has been considered to have a protective effect against the risk of fractures in adults. However, a high frequency of fracture is described in obese adults with Prader–Willi syndrome. To evaluate bone geometry, density and strength in a group of adult obese patients with Prader–Willi syndrome (PWS) and to examine the modulating effect on bone of treatment with growth hormone (GH) and sex steroids. This was a cross-sectional study performed in 41 (17 males, 24 females) obese subjects with genetically confirmed PWS, aged 29.4 ± 8.6 years. Forty-six healthy subjects (22 males and 24 females) served as controls. Digitalized X-rays were evaluated at the level of the 2nd metacarpal bone to assess bone geometry, i.e. cross-sectional area (CSA), cortical area (CA), medullary area (MA), metacarpal index (MI) and bone strength evaluated as bending breaking resistance index (BBRI). DEXA was also used to evaluate body composition and bone mineral density (total body, lumbar spine and femoral neck). PWS subjects, after adjusting for height and bone size, had a reduced CSA, CA and BBRI, while bone density was not different. GH treatment had a positive effect and sex steroids a negative effect on bone size and strength. PWS subjects showed a reduced bone size at the metacarpus leading to a reduced strength, while bone density was appropriate for size. GH treatment improves bone geometry but not bone density. Bone strength was significantly reduced in PWS patients who did not receive GH and had been treated with sex steroids.

Original languageEnglish
Pages (from-to)160-166
Number of pages7
JournalCalcified Tissue International
Volume96
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Growth Hormone
Steroids
Bone Density
Bone and Bones
Metacarpal Bones
Therapeutics
Metacarpus
Femur Neck
Body Composition
Healthy Volunteers
Spine
Obesity
Cross-Sectional Studies
X-Rays

Keywords

  • Bone density
  • Bone geometry
  • Obesity
  • Prader−Willi syndrome

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medicine(all)

Cite this

Adults with Prader–Willi Syndrome have Weaker Bones : Effect of Treatment with GH and Sex Steroids. / Longhi, Silvia; Grugni, Graziano; Gatti, Davide; Spinozzi, Emiliano; Sartorio, Alessandro; Adami, Silvano; Fanolla, Antonio; Radetti, Giorgio.

In: Calcified Tissue International, Vol. 96, No. 2, 2015, p. 160-166.

Research output: Contribution to journalArticle

Longhi, Silvia ; Grugni, Graziano ; Gatti, Davide ; Spinozzi, Emiliano ; Sartorio, Alessandro ; Adami, Silvano ; Fanolla, Antonio ; Radetti, Giorgio. / Adults with Prader–Willi Syndrome have Weaker Bones : Effect of Treatment with GH and Sex Steroids. In: Calcified Tissue International. 2015 ; Vol. 96, No. 2. pp. 160-166.
@article{efb832c43fcd4bf7b7f2a684af7316e5,
title = "Adults with Prader–Willi Syndrome have Weaker Bones: Effect of Treatment with GH and Sex Steroids",
abstract = "Obesity has been considered to have a protective effect against the risk of fractures in adults. However, a high frequency of fracture is described in obese adults with Prader–Willi syndrome. To evaluate bone geometry, density and strength in a group of adult obese patients with Prader–Willi syndrome (PWS) and to examine the modulating effect on bone of treatment with growth hormone (GH) and sex steroids. This was a cross-sectional study performed in 41 (17 males, 24 females) obese subjects with genetically confirmed PWS, aged 29.4 ± 8.6 years. Forty-six healthy subjects (22 males and 24 females) served as controls. Digitalized X-rays were evaluated at the level of the 2nd metacarpal bone to assess bone geometry, i.e. cross-sectional area (CSA), cortical area (CA), medullary area (MA), metacarpal index (MI) and bone strength evaluated as bending breaking resistance index (BBRI). DEXA was also used to evaluate body composition and bone mineral density (total body, lumbar spine and femoral neck). PWS subjects, after adjusting for height and bone size, had a reduced CSA, CA and BBRI, while bone density was not different. GH treatment had a positive effect and sex steroids a negative effect on bone size and strength. PWS subjects showed a reduced bone size at the metacarpus leading to a reduced strength, while bone density was appropriate for size. GH treatment improves bone geometry but not bone density. Bone strength was significantly reduced in PWS patients who did not receive GH and had been treated with sex steroids.",
keywords = "Bone density, Bone geometry, Obesity, Prader−Willi syndrome",
author = "Silvia Longhi and Graziano Grugni and Davide Gatti and Emiliano Spinozzi and Alessandro Sartorio and Silvano Adami and Antonio Fanolla and Giorgio Radetti",
year = "2015",
doi = "10.1007/s00223-014-9949-1",
language = "English",
volume = "96",
pages = "160--166",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Adults with Prader–Willi Syndrome have Weaker Bones

T2 - Effect of Treatment with GH and Sex Steroids

AU - Longhi, Silvia

AU - Grugni, Graziano

AU - Gatti, Davide

AU - Spinozzi, Emiliano

AU - Sartorio, Alessandro

AU - Adami, Silvano

AU - Fanolla, Antonio

AU - Radetti, Giorgio

PY - 2015

Y1 - 2015

N2 - Obesity has been considered to have a protective effect against the risk of fractures in adults. However, a high frequency of fracture is described in obese adults with Prader–Willi syndrome. To evaluate bone geometry, density and strength in a group of adult obese patients with Prader–Willi syndrome (PWS) and to examine the modulating effect on bone of treatment with growth hormone (GH) and sex steroids. This was a cross-sectional study performed in 41 (17 males, 24 females) obese subjects with genetically confirmed PWS, aged 29.4 ± 8.6 years. Forty-six healthy subjects (22 males and 24 females) served as controls. Digitalized X-rays were evaluated at the level of the 2nd metacarpal bone to assess bone geometry, i.e. cross-sectional area (CSA), cortical area (CA), medullary area (MA), metacarpal index (MI) and bone strength evaluated as bending breaking resistance index (BBRI). DEXA was also used to evaluate body composition and bone mineral density (total body, lumbar spine and femoral neck). PWS subjects, after adjusting for height and bone size, had a reduced CSA, CA and BBRI, while bone density was not different. GH treatment had a positive effect and sex steroids a negative effect on bone size and strength. PWS subjects showed a reduced bone size at the metacarpus leading to a reduced strength, while bone density was appropriate for size. GH treatment improves bone geometry but not bone density. Bone strength was significantly reduced in PWS patients who did not receive GH and had been treated with sex steroids.

AB - Obesity has been considered to have a protective effect against the risk of fractures in adults. However, a high frequency of fracture is described in obese adults with Prader–Willi syndrome. To evaluate bone geometry, density and strength in a group of adult obese patients with Prader–Willi syndrome (PWS) and to examine the modulating effect on bone of treatment with growth hormone (GH) and sex steroids. This was a cross-sectional study performed in 41 (17 males, 24 females) obese subjects with genetically confirmed PWS, aged 29.4 ± 8.6 years. Forty-six healthy subjects (22 males and 24 females) served as controls. Digitalized X-rays were evaluated at the level of the 2nd metacarpal bone to assess bone geometry, i.e. cross-sectional area (CSA), cortical area (CA), medullary area (MA), metacarpal index (MI) and bone strength evaluated as bending breaking resistance index (BBRI). DEXA was also used to evaluate body composition and bone mineral density (total body, lumbar spine and femoral neck). PWS subjects, after adjusting for height and bone size, had a reduced CSA, CA and BBRI, while bone density was not different. GH treatment had a positive effect and sex steroids a negative effect on bone size and strength. PWS subjects showed a reduced bone size at the metacarpus leading to a reduced strength, while bone density was appropriate for size. GH treatment improves bone geometry but not bone density. Bone strength was significantly reduced in PWS patients who did not receive GH and had been treated with sex steroids.

KW - Bone density

KW - Bone geometry

KW - Obesity

KW - Prader−Willi syndrome

UR - http://www.scopus.com/inward/record.url?scp=84922287210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922287210&partnerID=8YFLogxK

U2 - 10.1007/s00223-014-9949-1

DO - 10.1007/s00223-014-9949-1

M3 - Article

C2 - 25577526

AN - SCOPUS:84922287210

VL - 96

SP - 160

EP - 166

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 2

ER -